These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3488195)

  • 1. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands.
    Davies BI; Maesen FP
    Drugs; 1986; 31 Suppl 3():28-33. PubMed ID: 3488195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branhamella catarrhalis respiratory infections in The Netherlands.
    Maesen FP; Davies BI
    Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respiratory tract infection with Branhamella catarrhalis].
    Matsumoto K; Nagatake T; Uzuka Y; Rikitomi N; Noguchi Y
    Nihon Naika Gakkai Zasshi; 1982 Dec; 71(12):1696-702. PubMed ID: 6984859
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
    Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect pathogenicity of Branhamella catarrhalis.
    Brook I
    Drugs; 1986; 31 Suppl 3():97-102. PubMed ID: 3488202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of Branhamella catarrhalis and other commensal Neisseriaceae in clinical sputum specimens in Lagos, Nigeria.
    Obi MC; Animashaun T; Odugbemi T
    Eur J Epidemiol; 1990 Sep; 6(3):323-5. PubMed ID: 2123801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
    Robinson A; Johnson PC; Griffith SB
    Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.
    Pollard JA; Wallace RJ; Nash DR; Luman JI; Wilson RW
    Drugs; 1986; 31 Suppl 3():103-8. PubMed ID: 3488188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.
    Brorson JE; Martinell J; Wilske H
    J Antimicrob Chemother; 1981 Feb; 7(2):208-9. PubMed ID: 6971288
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy.
    Lundgren K; Ingvarsson L
    Drugs; 1986; 31 Suppl 3():125-31. PubMed ID: 3488192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increasing importance of Branhamella catarrhalis in respiratory infections.
    Van Hare GF; Shurin PA
    Pediatr Infect Dis J; 1987 Jan; 6(1):92-4. PubMed ID: 3547295
    [No Abstract]   [Full Text] [Related]  

  • 20. Branhamella catarrhalis and respiratory tract infections.
    Nicolas GM; Helmy MF; el-Said MK; Haroun AA; Aly AG
    J Egypt Public Health Assoc; 1991; 66(1-2):79-95. PubMed ID: 1800627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.